Zoetis Inc. (ZTS)
NYSE: ZTS · IEX Real-Time Price · USD
167.23
+8.73 (5.51%)
At close: May 2, 2024, 4:00 PM
167.28
+0.05 (0.03%)
After-hours: May 2, 2024, 4:31 PM EDT
Zoetis Revenue
In the year 2023, Zoetis had annual revenue of $8.54B with 5.74% growth. Revenue in the quarter ending December 31, 2023 was $2.21B with 8.48% year-over-year growth.
Revenue (ttm)
$8.54B
Revenue Growth
+5.74%
P/S Ratio
9.05
Revenue / Employee
$605,957
Employees
14,100
Market Cap
76.48B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
Dec 31, 2010 | 3.58B | 822.00M | 29.78% |
Dec 31, 2009 | 2.76B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 357.78B |
McKesson | 301.51B |
Cencora | 271.58B |
HCA Healthcare | 64.97B |
Bristol-Myers Squibb Company | 45.53B |
GSK | 38.39B |
Gilead Sciences | 27.12B |
Becton, Dickinson and Company | 19.49B |
ZTS News
- 8 hours ago - Zoetis beats profit estimates on strong demand for pet products - Reuters
- 9 hours ago - Zoetis Announces First Quarter 2024 Results - Business Wire
- 1 day ago - Zoetis Reports Earnings Thursday. The Company Must Address Dog Pain Drug Safety Worries. - Barrons
- 1 day ago - INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 3 days ago - Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health - Business Wire
- 5 days ago - ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS - PRNewsWire
- 7 days ago - Zoetis Foundation Champions Global Veterinarian Education, Well-being, and Livelihoods on World Veterinary Day and Beyond - Business Wire
- 10 days ago - IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire